BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 16094241)

  • 1. Broviac catheter-related candidemia.
    Castagnola E; Marazzi MG; Tacchella A; Giacchino R
    Pediatr Infect Dis J; 2005 Aug; 24(8):747. PubMed ID: 16094241
    [No Abstract]   [Full Text] [Related]  

  • 2. Candida glabrata fungemia cured by antibiotic-lock therapy: case report and short review.
    Angel-Moreno A; Boronat M; Bolaños M; Carrillo A; González S; Pérez Arellano JL
    J Infect; 2005 Oct; 51(3):e85-7. PubMed ID: 16230210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic approaches in patients with candidemia. Evaluation in a multicenter, prospective, observational study.
    Nguyen MH; Peacock JE; Tanner DC; Morris AJ; Nguyen ML; Snydman DR; Wagener MM; Yu VL
    Arch Intern Med; 1995 Dec 11-25; 155(22):2429-35. PubMed ID: 7503601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of central venous catheter fungal infection using liposomal amphotericin-B lock therapy.
    Buckler BS; Sams RN; Goei VL; Krishnan KR; Bemis MJ; Parker DP; Murray DL
    Pediatr Infect Dis J; 2008 Aug; 27(8):762-4. PubMed ID: 18664989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful treatment with caspofungin of refractory Candida krusei candidemia in a very low birth weight preterm infant.
    Natale F; Castronovo A; Regoli D; De Curtis M; Manzoni P
    Pediatr Infect Dis J; 2009 May; 28(5):452. PubMed ID: 19295457
    [No Abstract]   [Full Text] [Related]  

  • 6. Catheter-related fungemia caused by Candida intermedia.
    Ruan SY; Chien JY; Hou YC; Hsueh PR
    Int J Infect Dis; 2010 Feb; 14(2):e147-9. PubMed ID: 19497773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caspofungin treatment in two infants with persistent fungaemia due to Candida lipolytica.
    Belet N; Ciftçi E; Ince E; Dalgiç N; Oncel S; Güriz H; Yagmurlu A; Dindar H; Doğru U
    Scand J Infect Dis; 2006; 38(6-7):559-62. PubMed ID: 16798714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Problems and controversies in the management of hematogenous candidiasis.
    Uzun O; Anaissie EJ
    Clin Infect Dis; 1996 May; 22 Suppl 2():S95-101. PubMed ID: 8722835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Another patient with candida vertebral osteomyelitis treated with liposomal amphotericin B.
    Cone LA; Dreisbach L; Dreisbach P; Wuesthoff M
    Surg Neurol; 2005 Jun; 63(6):592. PubMed ID: 15936402
    [No Abstract]   [Full Text] [Related]  

  • 10. [Current candidiasis topics: monitoring Liposomal amphotericin B using candidiasis flow charts (discussion)].
    Takesue Y
    Jpn J Antibiot; 2012 Apr; 65(2):111-9. PubMed ID: 22970634
    [No Abstract]   [Full Text] [Related]  

  • 11. Central venous catheter-associated fungemia due to Rhodotorula spp. --a systematic review.
    Tuon FF; de Almeida GM; Costa SF
    Med Mycol; 2007 Aug; 45(5):441-7. PubMed ID: 17654271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Failure of a lipid amphotericin B preparation to eradicate candiduria: preliminary findings based on three cases.
    Agustin J; Lacson S; Raffalli J; Aguero-Rosenfeld ME; Wormser GP
    Clin Infect Dis; 1999 Sep; 29(3):686-7. PubMed ID: 10530471
    [No Abstract]   [Full Text] [Related]  

  • 13. [Candidemia: a never ceasing challenge].
    Muñoz García de Paredes P
    Rev Clin Esp; 1997 Dec; 197(12):795-7. PubMed ID: 9477668
    [No Abstract]   [Full Text] [Related]  

  • 14. Intravascular catheter exchange and duration of candidemia. NIAID Mycoses Study Group and the Candidemia Study Group.
    Rex JH; Bennett JE; Sugar AM; Pappas PG; Serody J; Edwards JE; Washburn RG
    Clin Infect Dis; 1995 Oct; 21(4):994-6. PubMed ID: 8645855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of candidemia on caspofungin therapy: a case report.
    Cheung C; Guo Y; Gialanella P; Feldmesser M
    Infection; 2006 Dec; 34(6):345-8. PubMed ID: 17180591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful treatment of catheter-related fusarial infection in immunocompromised children.
    Velasco E; Martins CA; Nucci M
    Eur J Clin Microbiol Infect Dis; 1995 Aug; 14(8):697-9. PubMed ID: 8565988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The patient with intravascular lines.
    Byl B
    Acta Clin Belg; 1998 Dec; 53(6):355-9. PubMed ID: 10023144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose liposomal amphotericin B in the therapy of systemic candidiasis in neonates.
    Juster-Reicher A; Flidel-Rimon O; Amitay M; Even-Tov S; Shinwell E; Leibovitz E
    Eur J Clin Microbiol Infect Dis; 2003 Oct; 22(10):603-7. PubMed ID: 13680398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liposomal amphotericin B in neonates with invasive candidiasis.
    Al Arishi H; Frayha HH; Kalloghlian A; Al Alaiyan S
    Am J Perinatol; 1998; 15(11):643-8. PubMed ID: 10064206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Current treatment of candidemia in non-neutropenic patients. Amphotericin B or fluconazole? A retrospective study of 62 consecutive patients].
    Cobo Reinoso P; Aguado García JM; Lumbreras Bermejo C; Pérez Vela JL; Caballero Cubedo R; Sanz Sanz F; Noriega Rodríguez AR
    Rev Clin Esp; 1997 Dec; 197(12):799-803. PubMed ID: 9477669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.